Header image

What About HER? HER2-Targeted Treatments in Lung Cancer

Friday, October 3, 2025
8:15 AM - 8:40 AM

Session Details

By the end of this session participants will be able to: 1. Describe the role of HER2 mutation, amplification, and overexpression in the development of lung cancer 2. Identify current and future HER2-targeted therapies in the treatment of lung cancer

loading